Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity
Authors:
- W. K. HongWHW. K. Hong
- C. Guillory-PerezCGC. Guillory-Perez
- S. M. LippmanSLS. M. Lippman
Open Access
- 1 January 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 8 (1) , 85-89
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Prevention of Second Primary Tumors by an Acyclic Retinoid, Polyprenoic Acid, in Patients with Hepatocellular CarcinomaNew England Journal of Medicine, 1996
- Suppression of Retinoic Acid Receptor–β in Premalignant Oral Lesions and Its Up-Regulation by IsotretinoinNew England Journal of Medicine, 1995
- A Pilot Study of Isotretinoin in the Treatment of Juvenile Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1994
- Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study.Journal of Clinical Oncology, 1994
- Cancer chemoprevention.Journal of Clinical Oncology, 1994
- Comparison of Low-Dose Isotretinoin with Beta Carotene to Prevent Oral CarcinogenesisNew England Journal of Medicine, 1993
- Retinoids in cancer therapy.Journal of Clinical Oncology, 1992
- Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 1990
- Prevention of Skin Cancer in Xeroderma Pigmentosum with the Use of Oral IsotretinoinNew England Journal of Medicine, 1988
- 13-cis-Retinoic Acid in the Treatment of Oral LeukoplakiaNew England Journal of Medicine, 1986